Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wave Life Sciences Ltd.

www.wavelifesciences.com

Latest From Wave Life Sciences Ltd.

Neurology At The Forefront Of US FDA Complex Innovative Trial Design Pilot

Wave’s Duchenne muscular dystrophy drug and Lilly’s chronic pain R&D will test the agency’s CID meeting pilot program, while FDA issues draft guidance that highlights potential uses for complex innovative trial designs.

Clinical Trials Neurology

US FDA And Sponsors Resolve Disclosure Issues On Complex Trial Design Pilot Projects

Agency officials can now discuss the ideas that have been accepted, though not in great detail.

Clinical Trials Research and Development Strategies

J.P. Morgan Stockwatch: No Substitute For M&A

Stock market reaction to the first day’s news from the 38th J.P. Morgan Healthcare conference in San Francisco was negative, probably because expectations for a continuation of December’s bumper M&A bonanza were too high.

M & A Advisory Committees

Wave Crashes Down On Duchenne Fail

Having spectacularly failed even to match Sarepta’s Exondys 51 in the restoration of dystrophin in Duchenne muscular dystrophy patients, Wave's future is dependent on soon-to-be published data on a Huntington’s disease therapy.

Clinical Trials Rare Diseases
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Tools
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Gastrointestinal
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ontorii Pharmaceuticals
  • Chiralgen
  • Wave Life Sciences Pte. Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Southeast Asia
        • Singapore
  • Parent & Subsidiaries
  • Wave Life Sciences Ltd.
  • Senior Management
  • Paul Bolno, MD, Pres. & CEO
    Keith Regnante, CFO
    Chris Francis, PhD, SVP, Corp. Dev.
    Chandra Vargeese, PhD, SVP, Drug Discovery
    Michael Panzara, MD, CMO
    Mark Baldry, Chief Commercial Officer
  • Contact Info
  • Wave Life Sciences Ltd.
    7 Straits View #12-00
    Marina One East
    , MA 018936
    Singapore
UsernamePublicRestriction

Register